10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
Harlan S. Robins, insider at Adaptive Biotechnologies

Harlan S. Robins Insider Information

Dr. Harlan Robins is the co-founder and Chief Scientific Officer of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Prior to co-founding Adaptive, Harlan served in various roles in the Computational Biology Program at Fred Hutch, including as an Assistant Faculty Member from 2006 to 2011, as an Associate from 2011 to April 2016, and as a Full Member and the Head of the program from April 2016 to June 2019. Harlan holds a BS in Physics from Harvard University and a master’s degree and PhD in Physics from the University of California, Berkeley, with a visiting appointment to the California Institute of Technology. Harlan received postdoctoral appointments in the particle theory group at the Weizmann Institute of Science in Israel and at the Institute for Advanced Study in Princeton, NJ.

What is Harlan S. Robins' net worth?

The estimated net worth of Harlan S. Robins is at least $2.69 million as of July 21st, 2021. Dr. Robins owns 73,255 shares of Adaptive Biotechnologies stock worth more than $2,685,528 as of July 31st. This net worth approximation does not reflect any other investments that Dr. Robins may own.

What is Harlan S. Robins' salary?

As the Insider of Adaptive Biotechnologies Co., Dr. Robins earned a total compensation package of $6,761,270.00 in 2020. Dr. Robins earned a salary of $493,750.00, options awards of $6,013,620.00, non-equity compensation of $250,000.00, and other compensation of $3,900.00.

How do I contact Harlan S. Robins?

The corporate mailing address for Dr. Robins and other Adaptive Biotechnologies executives is 1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE WA, 98102. Adaptive Biotechnologies can also be reached via phone at (206) 659-0067 and via email at [email protected]

Has Harlan S. Robins been buying or selling shares of Adaptive Biotechnologies?

Within the last three months, Harlan S. Robins has sold $147,309.00 in Adaptive Biotechnologies stock. Most recently, Harlan S. Robins sold 3,895 shares of the business's stock in a transaction on Wednesday, July 21st. The shares were sold at an average price of $37.82, for a transaction totalling $147,308.90. Following the completion of the sale, the insider now directly owns 73,255 shares of the company's stock, valued at $2,770,504.10.

Who are Adaptive Biotechnologies' active insiders?

Adaptive Biotechnologies' insider roster includes R. Adams (COO), Sharon Benzeno (Insider), Chad Cohen (CFO), Chad Cohen (CFO), Egon Durban (Director), Michelle Griffin (Director), Francis Lo (Insider), Jyoti Palaniappan (SVP), Chad Robins (CEO), Chad Robins (CEO), Harlan Robins (Insider), Harlan Robins (Insider), and Stacy Taylor (SVP).

Are insiders buying or selling shares of Adaptive Biotechnologies?

During the last twelve months, insiders at the sold shares 157 times. They sold a total of 6,218,199 shares worth mmore than $321,225,453.70. The most recent insider tranaction occured on July, 21st when Harlan S Robins Insider bought 3,895 shares worth more than $147,308.90. Insiders at Adaptive Biotechnologies own 34.7 % of the company.

Information on this page was last updated on 7/21/2021.

Harlan S. Robins Insider Trading History at Adaptive Biotechnologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/21/2021Sell3,895$37.82$147,308.9073,255View SEC Filing Icon  
6/11/2021Sell3,895$38.41$149,606.9573,255View SEC Filing Icon  
6/9/2021Sell3,895$35.99$140,181.0573,255View SEC Filing Icon  
5/6/2021Sell3,895$35.70$139,051.5073,255View SEC Filing Icon  
5/4/2021Sell3,895$36.14$140,765.3073,255View SEC Filing Icon  
4/22/2021Sell7,790$43.18$336,372.2081,045View SEC Filing Icon  
4/20/2021Sell11,685$40.52$473,476.2081,045View SEC Filing Icon  
3/25/2021Sell5,290$38.30$202,607.0077,150View SEC Filing Icon  
3/23/2021Sell7,790$41.93$326,634.7077,150View SEC Filing Icon  
2/3/2021Sell7,790$59.58$464,128.208,469View SEC Filing Icon  
2/1/2021Sell7,790$55.83$434,915.708,469View SEC Filing Icon  
1/21/2021Sell23,370$66.82$1,561,583.4024,049View SEC Filing Icon  
11/6/2020Sell33,300$50.70$1,688,310.0011,779View SEC Filing Icon  
11/4/2020Sell11,100$50.29$558,219.0011,779View SEC Filing Icon  
10/15/2020Sell11,100$51.55$572,205.0011,779View SEC Filing Icon  
9/23/2020Sell11,100$48.16$534,576.0011,779View SEC Filing Icon  
8/21/2020Sell33,300$42.84$1,426,572.0011,779View SEC Filing Icon  
7/17/2020Sell33,300$39.58$1,318,014.0022,879View SEC Filing Icon  
6/25/2020Sell11,100$46.88$520,368.0011,779View SEC Filing Icon  
6/23/2020Sell11,100$46.85$520,035.0011,779View SEC Filing Icon  
5/20/2020Sell31,372$40.48$1,269,938.5632,051View SEC Filing Icon  
5/18/2020Sell11,100$39.32$436,452.00101,879View SEC Filing Icon  
5/14/2020Sell31,200$35.32$1,101,984.00101,879View SEC Filing Icon  
4/22/2020Sell25,600$30.28$775,168.0085,579View SEC Filing Icon  
4/20/2020Sell14,900$28.83$429,567.0085,579View SEC Filing Icon  
1/17/2020Sell3,700$27.96$103,452.0074,379View SEC Filing Icon  
1/15/2020Sell3,700$29.52$109,224.0074,379View SEC Filing Icon  
See Full Table

Harlan S. Robins Buying and Selling Activity at Adaptive Biotechnologies

This chart shows Harlan S Robins's buying and selling at Adaptive Biotechnologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adaptive Biotechnologies Company Overview

Adaptive Biotechnologies logo
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.
Read More

Today's Range

Now: $36.66
Low: $36.24
High: $37.18

50 Day Range

MA: $38.04
Low: $34.12
High: $42.40

2 Week Range

Now: $36.66
Low: $30.41
High: $71.25


279,300 shs

Average Volume

472,444 shs

Market Capitalization

$5.14 billion

P/E Ratio


Dividend Yield



Your 15 Minute Workday… (Make Extra Cash from Home)
Some people binge watch Netflix… Hulu…or HBO shows. And some people turn their downtime into cash. James made $2,275 in just 19 minutes…all thanks to something called The 15 Minute Workday. The average trade makes 12% in just 5 days (factoring winners and losers) which is out of this world.
Click here to start